What is the clinical evidence from this study?

Study design: Cohort. Population: Mechanical heart valve replacement requiring oral anticoagulation (n=41). Intervention: Self-management of oral anticoagulant therapy using CoaguChek monitor vs. Conventional management. Primary outcome: Time within therapeutic target range (INR 2.0-3.0).

What question did this study set out to answer?

The study aims to explore whether patients can effectively manage their own oral anticoagulant therapy post heart valve replacement.

May 1, 1997European Journal of Cardio-Thoracic SurgeryOpen Access

Self management of oral anticoagulant therapy after heart valve replacement

View Full Paper

Ask AI

Bookmark

Key result

Self-management of oral anticoagulation using a CoaguChek monitor increased the time within therapeutic target range to 77% compared with 53% for conventional management.

Why the study?

Does self-management of oral anticoagulant therapy improve time in therapeutic range in patients after heart valve replacement?

Key Points

The study aims to explore whether patients can effectively manage their own oral anticoagulant therapy post heart valve replacement.
Enrolled 21 patients and trained them on CoaguChek INR monitors post heart valve surgery.
Conducted laboratory INR comparisons with a control group of 20 patients at intervals during a 9-month follow-up.
Established INR target range of 2.0-3.0 for effective self management.
19 out of 21 study patients continued self management beyond 9 months.
Median INR for study patients remained within the therapeutic target range compared to 15 out of 20 control patients.
Study patients maintained therapeutic range 77% of the time versus 53% for control patients.

Study Design

Type

Cohort (n=41)

Structured PICO

Does self-management of oral anticoagulant therapy improve time in therapeutic range in patients after heart valve replacement?

Population

41 patients (21 study, 20 control) who underwent heart valve replacement requiring lifelong oral anticoagulant treatment

Intervention

Self-management of blood specimen analysis and dosage adjustment using a CoaguChek INR monitor

Comparator

Conventional management (matched control group)

Outcome

Time within therapeutic target range (INR 2.0-3.0)surrogate

Main Result

Absolute Event Rate: 77% vs 53%

Self-management of oral anticoagulation using a point-of-care monitor is feasible and improves time in therapeutic range compared to conventional management in patients with mechanical heart valves.

Limitations

Small sample size insufficient to assess the rate of bleeding and thrombo-embolic events.
Small sample size, insufficient to assess rate of bleeding and thrombo-embolic events

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Self-management may enhance TTR post-valve replacement; leaves open confirmation in randomized trials before practice change.

Cite This Study

J. Michael Hasenkam (1997) conducted a cohort in Mechanical heart valve replacement requiring oral anticoagulation (n=41). Self-management of oral anticoagulant therapy using CoaguChek monitor vs. Conventional management was evaluated on Time within therapeutic target range (INR 2.0-3.0). Self-management of oral anticoagulation using a CoaguChek monitor increased the time within therapeutic target range to 77% compared with 53% for conventional management.

synapsesocial.com/papers/6a0827a01e8b9db648ddf4d8 https://doi.org/10.1016/s1010-7940(97)01204-9

Topics

Anticoagulation in AF

View Full Paper

Ask AI

Bookmark

Self management of oral anticoagulant therapy after heart valve replacement

Key Points

Study Design

Structured PICO

Main Result

Limitations

Discussion

Implication

Cite This Study

Topics

Self management of oral anticoagulant therapy after heart valve replacement

Key Points

Study Design

Structured PICO

Main Result

Limitations

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider